Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns
1. 系统已在2026-09-30 20:42:51对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1016/j.ejca.2026.117036
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0959804926008178
其他信息:
出版社: Elsevier BV
作者: Simona Casalino; Enza Scarlato; Marina Crespo Cruz; Christoph Gerdes; Anna Sordo; Alberto Quinzii; Camilla Zecchetto; Luisa Messineo; Ester Tasselli; Lucia Mendo; Anna Saborowski; John Bridgewater; Arndt Vogel; Davide Melisi

